esc semaglutide STEP-HFpEF Trial STEP-HFpEF Trial
Description
Used as part of combination therapy to support weight loss and reduce food cravings in metabolic programs.
Yes, tirzepatide commonly causes acid indigestion (dyspepsia) as a gastrointestinal side effect
Supported by NZD $30 million of funding and over ten years of research by the New Zealand Institute for Plant and Food Research Limited, a New Zealand government-owned Crown Research Institute
GLP-1 therapies have cracked the efficacy ceiling
Glucagon-like peptide-1 (GLP-1) receptor agonists, especially semaglutide, are associated with a reduced risk for worsening of anxiety and depression that co-oc
